Sudo Biosciences Doses First Participants in TYK2 Inhibitor Trial
02 Dec 2024 //
BUSINESSWIRE
Damona Pharmaceuticals Receives FDA Clearance for DPX-101 IND
04 Nov 2024 //
PR NEWSWIRE
Atavistik Bio Presents Preclinical Data on ATV-1601 at EORTC
23 Oct 2024 //
GLOBENEWSWIRE
Gain Therapeutics Presents Data on DDR2 Inhibitors at EORTC
23 Oct 2024 //
GLOBENEWSWIRE
Allos Pharma Inc. Expands Intellectual Property Rights for Arbaclofen
18 Sep 2023 //
PR NEWSWIRE
Allos Receives FDA Guidance for the Design of a Phase 3 Trial to Support a NDA
23 May 2023 //
PR NEWSWIRE
Allos Pharma presents new positive data analyses at the 18th NFXF Conference
14 Jul 2022 //
PRNEWSWIRE
NIH urged to `break taboo` against using its power to bypass drug patents
15 Jan 2016 //
FIERCE PHARMA